uniQure N.V. (QURE)
uniQure N.V. (QURE) stock sees increased social media buzz following positive FDA Type A meeting news for AMT-130, fueling hopes for accelerated approval. Unusual options activity shows strong bullish sentiment with significant call buying.
About uniQure N.V.
uniQure N.V. is a biotechnology company focused on gene therapy for severe diseases.
uniQure N.V. uses the ticker $QURE for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- uniQure N.V. (QURE) social dominance is up 861.2% from the previous week.
- uniQure N.V. (QURE) creators is up 50.83% from the previous week.
- uniQure N.V. (QURE) mentions is up 84.67% from the previous week.
Price: $20.50
Price 24-Hour Time-Series Raw Data
The stock price has seen a significant increase, driven by positive news regarding the FDA Type A meeting for AMT-130 and renewed hope for accelerated approval, as reflected in increased social media engagement and positive sentiment. Unusual options activity shows significant call buying at the $70 strike, indicating strong bullish sentiment.
24-Hour: -8.36% 7-Day: -19.58% 30-Day: -10.25%
1-Year High: $70.60 on 2025-10-29
1-Year Low: $8.30 on 2025-04-08
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
uniQure N.V. (QURE) is currently AltRank #497 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] +298
[--] Month: [---] +57
[--] Months: [---] +130
[--] Year: [---] +106
1-Year High: [-----] on 2026-01-28
1-Year Low: [--] on 2025-09-27
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +8
1-Year High: [--] on 2026-01-09
1-Year Low: [--] on 2025-12-11
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] -26%
[--] Month: [---------] +16%
[--] Months: [----------] +339%
[--] Year: [----------] +496%
1-Year High: [---------] on 2025-09-24
1-Year Low: [-----] on 2025-03-08
Engagements by network (24h): News: [---] YouTube: [--] Reddit: [--] X: [------]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +85%
[--] Month: [-----] +13%
[--] Months: [------] +526%
[--] Year: [------] +354%
1-Year High: [-----] on 2025-09-25
1-Year Low: [--] on 2025-04-07
Mentions by network (24h): News: [--] YouTube: [--] Reddit: [--] X: [---]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning uniQure N.V. (QURE) in the last [--] hours which is down 13% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] +51%
[--] Month: [---] -6.20%
[--] Months: [-----] +355%
[--] Year: [-----] +543%
1-Year High: [-----] on 2025-09-25
1-Year Low: [--] on 2025-04-07
The most influential creators that mention uniQure N.V. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @peter_mantas | [--] | [-----] | [--] | [------] |
| @mike98572986 | [--] | [-----] | [--] | [-----] |
| @Tim_Corr | [--] | [---] | [--] | [-----] |
| @TraderNorway | [--] | [---] | [--] | [---] |
| @Prof_Dollar | [--] | [-----] | [--] | [---] |
| @DesertDweller93 | [--] | [-----] | [--] | [---] |
| @jawnzilla | [--] | [---] | [--] | [---] |
| @CryptoProJoe | [--] | [---] | [--] | [---] |
| @Lucy3370 | [--] | [-----] | [--] | [---] |
| @BOSSTRADING0 | [--] | [-----] | [--] | [---] |
Sentiment: 80%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 80%
Daily Average: 83%
[--] Week: 79% +7%
[--] Month: 76% +2%
[--] Months: 76% -8%
[--] Year: 76% -20%
1-Year High: 100% on 2025-03-14
1-Year Low: 40% on 2025-04-14
Most Supportive Themes:
- Positive Clinical Trial Results: (30%) Posts highlight recent positive clinical trial data, suggesting potential for future growth and success in the company's gene therapy treatments.
- Analyst Recommendations: (25%) Users are referencing positive analyst ratings and price targets, indicating a belief that the stock is currently undervalued.
- Stock Picks and Strategies: (20%) QURE is frequently recommended as a stock pick by users sharing investment strategies, suggesting confidence in its market performance.
Most Critical Themes:
- Concerns Over Clinical Trial Data Validity: (40%) Some posts express skepticism regarding the reliability of the clinical trial data and the potential for negative outcomes.
- Market Volatility Concerns: (35%) Users are discussing the impact of overall market conditions and potential volatility on QURE's stock price.
Social Dominance: 0.015%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.015%
Daily Average: 0.025%
[--] Week: 0.369% +0.331%
[--] Month: 0.018% -0.0019%
[--] Months: 0.018% +0.0073%
[--] Year: 0.018% +0.0061%
1-Year High: 0.228% on 2025-09-25
1-Year Low: 0.0049% on 2025-04-07
Market Dominance: 0.00146%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00146%
Daily Average: 0%
1-Year High: 0.116% on 2025-10-31
1-Year Low: 0.00146% on 2026-02-16
Market Cap: $1,289,437,424
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,289,437,424
Daily Average: $2,088,345,752
[--] Week: $1,280,093,675 -18%
[--] Month: $1,276,979,092 -10%
1-Year High: $4,348,610,195 on 2025-10-29
1-Year Low: $761,004,319 on 2025-09-19
Top uniQure N.V. News
Top news links shared on social in the last [--] hours
Showing a maximum of [--] news posts without a LunarCrush subscription.
"uniQure N.V. Ordinary Shares (QURE) Institutional Holdings Nasdaq Find the latest institutional holdings data for uniQure N.V. Ordinary Shares (QURE) including shareholders ownership summaries and holding activities at Nasdaq.com"
News Link @Nasdaq 2026-02-09T13:25Z 170.7K followers, [----] engagements
Top uniQure N.V. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"@JialiangLiang @CryptoProJoe $qure yes joe makes a good point. There r various scenarios folks have mentioned. People r guessing when meeting took place outcome etc - personally hope best outcome for HD patients-limited my personal $$ exposure -waiting 4minutes-no need 2guess anymore"
X Link @Lucy3370 2026-02-16T17:49Z [----] followers, [---] engagements
"$qure $clpt Check this out https://t.co/fhd8kV7bDj. Some pretty strong language just in time for patient access to innovative rare disease medicines. Let us see how MM & VP talk the talk but all bad actions Check this out https://t.co/fhd8kV7bDj. Some pretty strong language just in time for patient access to innovative rare disease medicines. Let us see how MM & VP talk the talk but all bad actions"
X Link @mike98572986 2026-02-16T05:56Z [----] followers, [----] engagements
"@peter_mantas @SmileysWord @HScottMatusow A huge week is coming guys. Not only just for $QURE + $CLPT stock but also for the HD community + all other gene therapy treatments. Godspeed everyone"
X Link @B0thSidesNow 2026-02-15T20:52Z [---] followers, [----] engagements
"That's enough. I have been involved with $CLPT since [----] and I was on the board of one of their vendors. You can look that up for yourself. I have been involved with $QURE since 2022/23 and know all of $CLPT's partner programs intimately. You can also look that up. My edge comes from proximity and this accusation will not be tolerated. https://twitter.com/i/web/status/2023128045570154642 https://twitter.com/i/web/status/2023128045570154642"
X Link @peter_mantas 2026-02-15T20:11Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing